FDA Modernization Act reauthorized the Prescription Drug User Fee Act of 2017
On Sept. 30, 2022, the U.S. Food and Drug Administration Modernization Act reauthorized the Prescription Drug User Fee…
On Sept. 30, 2022, the U.S. Food and Drug Administration Modernization Act reauthorized the Prescription Drug User Fee…
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
On Sept. 28, 2022, the Oregon Department of Agriculture and the U.S. Department of Agriculture’s Animal Plant Health…
On Sept. 28, 2022, Moderna announced that the European Medicines Agency (EMA) had accepted a variation for the…
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
On Sept. 27, 2022, Novavax announced that an initial one million doses of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine were…
On Sept. 28, 2022, Pfizer and BioNTech announced they have completed a submission to the U.S. Food and…
On Sept. 23, 2022, researchers at Tufts University announced they had developed a method to make silk-based materials…
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
On Sept. 21, 2022, the AACR released the 12th edition of its AACR Cancer Progress Report, an annual…
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health had granted an import and use…
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organizationメs Therapeutics and COVID-19: living guideline,…
On Sept. 15, 2022, the National Institutes of Health announced that a research team funded by the NIH…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
On Sept. 12, 2022, the White House announced an executive order to advance biotechnology and biomanufacturing towards innovative…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Sept. 8, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service launched an updated…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…